医学
生物标志物
内科学
肿瘤科
乳腺癌
梅德林
疾病
荟萃分析
妇科
生物信息学
作者
A.W. Islam,Harsahaj Singh Wilkhoo
出处
期刊:ESMO open
[Elsevier BV]
日期:2026-05-01
卷期号:11: 107135-107135
标识
DOI:10.1016/j.esmoop.2026.107135
摘要
Biomarker guided therapy is central to breast cancer management; however, discordance between primary tumors and metastatic lesions may compromise treatment selection. We conducted a systematic review and meta-analysis to quantify the frequency of primary metastatic biomarker discordance and evaluate its clinical impact.
科研通智能强力驱动
Strongly Powered by AbleSci AI